As shown in Figure 1b (p < 0.05), MEIS1 was differentially expressed in ACC, acute myeloid leukemia (LAML), skin cutaneous melanoma (SKCM), testicular germ cell tumors (TGCT), thymoma (THYM) and uterine carcinosarcoma (UCS), which was down-regulated in ACC, SKCM, TGCT and UCS, and up-regulated in LAML and THYM. This evidence concerns the gene MEIS1 and uterine carcinosarcoma.